Literature DB >> 24007728

Neuroimaging findings of the post-treatment effects of radiation and chemotherapy of malignant primary glial neoplasms.

M D Mamlouk1, J Handwerker, J Ospina, A N Hasso.   

Abstract

Post-treatment radiation and chemotherapy of malignant primary glial neoplasms present a wide spectrum of tumor appearances and treatment-related entities. Radiologic findings of these post-treatment effects overlap, making it difficult to distinguish treatment response and failure. The purposes of this article are to illustrate and contrast the imaging appearances of recurrent tumor from necrosis and to discuss other radiologic effects of cancer treatments. It is critical for radiologists to recognize these treatment-related effects to help direct clinical management.

Entities:  

Mesh:

Year:  2013        PMID: 24007728      PMCID: PMC4202820          DOI: 10.1177/197140091302600405

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  57 in total

1.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

Authors:  Patrick Y Wen; David R Macdonald; David A Reardon; Timothy F Cloughesy; A Gregory Sorensen; Evanthia Galanis; John Degroot; Wolfgang Wick; Mark R Gilbert; Andrew B Lassman; Christina Tsien; Tom Mikkelsen; Eric T Wong; Marc C Chamberlain; Roger Stupp; Kathleen R Lamborn; Michael A Vogelbaum; Martin J van den Bent; Susan M Chang
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

2.  Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.

Authors:  L S Hu; L C Baxter; K A Smith; B G Feuerstein; J P Karis; J M Eschbacher; S W Coons; P Nakaji; R F Yeh; J Debbins; J E Heiserman
Journal:  AJNR Am J Neuroradiol       Date:  2008-12-04       Impact factor: 3.825

Review 3.  MR spectroscopy in radiation injury.

Authors:  P C Sundgren
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-15       Impact factor: 3.825

4.  Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Ramon F Barajas; Jamie S Chang; Mark R Segal; Andrew T Parsa; Michael W McDermott; Mitchel S Berger; Soonmee Cha
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

5.  Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

Authors:  Whitney B Pope; Hyun J Kim; Jing Huo; Jeffry Alger; Matthew S Brown; David Gjertson; Victor Sai; Jonathan R Young; Leena Tekchandani; Timothy Cloughesy; Paul S Mischel; Albert Lai; Phioanh Nghiemphu; Syed Rahmanuddin; Jonathan Goldin
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

6.  Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.

Authors:  Rajiv Mangla; Gurshawn Singh; Doerthe Ziegelitz; Michael T Milano; David N Korones; Jianhui Zhong; Sven E Ekholm
Journal:  Radiology       Date:  2010-06-07       Impact factor: 11.105

7.  Evolution of radiation-induced brain injury: MR imaging-based study.

Authors:  Yi-Xiang J Wang; Ann D King; Hua Zhou; Sing-Fei Leung; Jill Abrigo; Yu-Leung Chan; Chen-Wen Hu; David K W Yeung; Anil T Ahuja
Journal:  Radiology       Date:  2009-12-17       Impact factor: 11.105

8.  Intracranial malignancies occurring more than 20 years after radiation therapy for pituitary adenoma.

Authors:  Wen Ying Wu-Chen; Dina A Jacobs; Nicholas J Volpe; Joseph O Dalmau; Mark L Moster
Journal:  J Neuroophthalmol       Date:  2009-12       Impact factor: 3.042

Review 9.  Pseudoprogression and pseudoresponse: challenges in brain tumor imaging.

Authors:  Jennifer L Clarke; Susan Chang
Journal:  Curr Neurol Neurosci Rep       Date:  2009-05       Impact factor: 5.081

10.  MR imaging of late radiation therapy- and chemotherapy-induced injury: a pictorial essay.

Authors:  L Pruzincová; J Steno; M Srbecký; P Kalina; B Rychlý; E Boljesíková; M Chorváth; M Novotný; V Procka; I Makaiová; V Belan
Journal:  Eur Radiol       Date:  2009-05-27       Impact factor: 5.315

View more
  6 in total

Review 1.  Current Clinical Brain Tumor Imaging.

Authors:  Javier E Villanueva-Meyer; Marc C Mabray; Soonmee Cha
Journal:  Neurosurgery       Date:  2017-09-01       Impact factor: 4.654

2.  Radiation-induced accelerated aging of the brain vasculature in young adult survivors of childhood brain tumors.

Authors:  Tiina Maria Remes; Maria Helena Suo-Palosaari; Päivi K T Koskenkorva; Anna K Sutela; Sanna-Maria Toiviainen-Salo; Pekka M Arikoski; Mikko O Arola; Vesa-Pekka Heikkilä; Mika Kapanen; Päivi Maria Lähteenmäki; Tuula R I Lönnqvist; Hannele Niiniviita; Tytti M-L Pokka; Liisa Porra; V Pekka Riikonen; Jan Seppälä; Kirsti H Sirkiä; Antti Vanhanen; Heikki M J Rantala; Arja H Harila-Saari; Marja K Ojaniemi
Journal:  Neurooncol Pract       Date:  2020-02-07

3.  Risk factors of radiotherapy-induced cerebral microbleeds and serial analysis of their size compared with white matter changes: A 7T MRI study in 113 adult patients with brain tumors.

Authors:  Melanie A Morrison; Christopher P Hess; Jennifer L Clarke; Nicholas Butowski; Susan M Chang; Annette M Molinaro; Janine M Lupo
Journal:  J Magn Reson Imaging       Date:  2019-01-20       Impact factor: 4.813

4.  Evaluation of normal-appearing white matter with perfusion and diffusion MRI in patients with treated glioblastoma.

Authors:  Sinan Şahin; Ersen Ertekin; Tuna Şahin; Yelda Özsunar
Journal:  MAGMA       Date:  2021-12-24       Impact factor: 2.310

5.  Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3-4) Gliomas.

Authors:  Christina M Flies; Karlijn H van Leuken; Marlies Ten Voorde; Joost J C Verhoeff; Filip Y F De Vos; Tatjana Seute; Pierre A Robe; Theodoor D Witkamp; Jeroen Hendrikse; Jan Willem Dankbaar; Tom J Snijders
Journal:  Neurology       Date:  2022-04-18       Impact factor: 11.800

6.  Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.

Authors:  Mojgan Hojjati; Chaitra Badve; Vasant Garg; Curtis Tatsuoka; Lisa Rogers; Andrew Sloan; Peter Faulhaber; Pablo R Ros; Leo J Wolansky
Journal:  J Neuroimaging       Date:  2017-07-18       Impact factor: 2.486

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.